Biblioteca Digital de l'Hospital Universitari Vall d'Hebron. ICS, 05 Feb 2018 A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the…